Journal of Pharmacology and Experimental Therapeutics: 278 (2)

August 01, 1996; Volume 278,Issue 2

You have access
Regulation of corticotropin-releasing factor-binding protein expression in cultured rat astrocytes.
D Maciejewski, P D Crowe, E B De Souza and D P Behan

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 455-461;
You have access
The presynaptic alpha-2 autoreceptors in pig brain cortex are alpha-2A.
A U Trendelenburg, N Limberger and K Starke

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 462-467;
You have access
Angiotensin II-mediated activation of L-type calcium channels involves phosphatidylinositol hydrolysis-independent activation of protein kinase C in rat portal vein myocytes.
N Macrez-Leprêtre, J L Morel and J Mironneau

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 468-475;
You have access
Thrombin stimulates atrial natriuretic peptide secretion from rat cardiac atrium.
L Klapper, S Nachshon, O Zamir and N Zamir

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 476-481;
You have access
Modulation by cyclic AMP of beta adrenergic receptor-stimulated prostacyclin synthesis in rabbit ventricular myocytes.
Y Ruan, H Kan and K U Malik

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 482-489;
You have access
Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine.
C A Heidbreder, A C Thompson and T S Shippenberg

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 490-502;
You have access
Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
M D Nyby, M Sasaki, Y Ideguchi, H E Wynne, M T Hori, M E Berger, M S Golub, A S Brickman and M L Tuck

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 503-509;
You have access
Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal.
L L Devaud, R H Purdy, D A Finn and A L Morrow

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 510-517;
You have access
Role of phospholipase C and phospholipase A2 in the nitric oxide-independent vasodilator effect of bradykinin in the rat perfused heart.
D Fulton, J C McGiff and J Quilley

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 518-526;
You have access
Functional characterization of alpha-1-adrenoceptor subtypes in the prostatic urethra and trigone of male rabbit.
V Deplanne and A M Galzin

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 527-534;
You have access
Vascular hyporesponsiveness in aorta from portal hypertensive rats: possible sites of involvement.
Y T Huang, G F Wang, M C Yang, S P Chang, H C Lin and C Y Hong

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 535-541;
You have access
Interactions between ethanol, endogenous adenosine and adenosine uptake in hippocampal brain slices.
L Diao and T V Dunwiddie

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 542-546;
You have access
Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
J D Wagstaff, J W Gibb and G R Hanson

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 547-554;
You have access
Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
K Muraki, H Nakagawa, N Nagano, S Henmi, H Kawasumi, T Nakanishi, K Imaizumi, T Tokuno, K Atsuki, Y Imaizumi and M Watanabe

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 555-563;
You have access
Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes.
T Nakamura, A Hisaka, Y Sawasaki, Y Suzuki, T Fukami, K Ishikawa, M Yano and Y Sugiyama

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 564-572;
You have access
Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
W Gonzalez, F Beslot, I Laboulandine, M C Fournié-Zaluski, B P Roques and J B Michel

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 573-581;
You have access
Mechanism mediating basolateral transport of 2,4-dichlorophenoxyacetic acid in rat kidney.
A R Villalobos, C A Dunnick and J B Pritchard

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 582-589;
You have access
Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs.
T Ooie, H Suzuki, T Terasaki and Y Sugiyama

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 590-596;
You have access
Mechanism of alpha-2 adrenergic modulation of canine cardiac Purkinje action potential.
H C Lee, J J Cai, D O Arnar, E F Shibata and J B Martins

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 597-606;
You have access
The endothelin receptor is a major determinant for the nonlinear tissue distribution of the endothelin antagonist BQ-123.
H C Shin, Y Kato, Y Shitara, T Yamada, T Nakamura, A Hisaka and Y Sugiyama

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 607-613;
You have access
Effect of vinconate, an indolonaphthyridine derivative, on dopamine and serotonin concentrations in dialysate from the striatum of freely moving rats: brain microdialysis studies.
T Iino, M Katsura and K Kuriyama

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 614-619;
You have access
gamma-Aminobutyric acidA receptors and spinally mediated antinociception in rats.
R Nadeson, Z Guo, V Porter, J P Gent and C S Goodchild

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 620-626;
You have access
Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus.
A Arai, M Kessler, G Rogers and G Lynch

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 627-638;
You have access
Simultaneous measurement of cyclopentyladenosine-induced contraction and intracellular calcium in bronchial rings from allergic rabbits and it's antagonism.
S Ali, W J Metzger and S J Mustafa

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 639-644;
You have access
Phospholipase D activity regulates the binding of leukotriene B4 to human polymorphonuclear leukocytes.
D Kiel and S J Feinmark

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 645-653;
You have access
Neurokinetic and myokinetic effects of the peptide xenin on the motility of the small and large intestine of guinea pig.
G E Feurle, A Klein, G Hamscher, J W Metzger and J A Schuurkes

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 654-661;
You have access
Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptors.
I S Hoffmann, R K Talmaciu, R Aquino and L X Cubeddu

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 662-668;
You have access
Block of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by polyamines and polyamine toxins.
M S Washburn and R Dingledine

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 669-678;
You have access
Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
R Corradetti, E Le Poul, N Laaris, M Hamon and L Lanfumey

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 679-688;
You have access
Morphine-induced alterations in antibody levels: receptor and immune mechanisms.
L L Lockwood, L H Silbert, M R Fleshner, C McNeal, L R Watkins, M L Laudenslager, K C Rice, R J Weber and S F Maier

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 689-696;
You have access
Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats.
F J van der Staay, V C Hinz and B H Schmidt

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 697-708;
You have access
Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats.
J L Valentine, M Mayersohn, W D Wessinger, L W Arnold and S M Owens

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 709-716;
You have access
Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats.
J L Valentine and S M Owens

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 717-724;
You have access
Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission.
W H Pan, J C Sung and S M Fuh

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 725-731;
You have access
Pharmacologic characteristics of potentiation of 5-HT3 receptors by alcohols and diethyl ether in NCB-20 neuroblastoma cells.
Q Zhou and D M Lovinger

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 732-740;
You have access
A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia.
S Hoshida, N Yamashita, J Igarashi, M Nishida, M Hori, T Kuzuya and M Tada

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 741-746;
You have access
Human brain cholecystokinin: release of cholecystokinin-like immunoreactivity (CCK-LI) from isolated cortical nerve endings and its modulation through GABA(B) receptors.
M Raiteri, G Bonanno, P Paudice, P Cavazzani and G Schmid

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 747-751;
You have access
WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
C A Fornal, C W Metzler, R A Gallegos, S C Veasey, A C McCreary and B L Jacobs

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 752-762;
You have access
Mechanisms of plumbagin action on guinea pig isolated atria.
M Floreani, A Forlin, L Pandolfo, M Petrone and S Bellin

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 763-770;
You have access
Effect of quercitrin on acute and chronic experimental colitis in the rat.
F Sánchez de Medina, J Gálvez, J A Romero and A Zarzuelo

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 771-779;
You have access
Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.
H Kawai, S Yuki, J Sugimoto and Y Tamao

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 780-785;
You have access
Mechanism of stereoselective serum binding of ketoprofen after hemodialysis.
T Sakai, T Maruyama, H Imamura, H Shimada and M Otagiri

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 786-792;
You have access
Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion.
T Chiu and I A Reid

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 793-799;
You have access
Agonist synergism in airway smooth muscle contraction.
W T Gerthoffer

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 800-807;
You have access
Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
S D Hess, L P Daggett, J Crona, C Deal, C C Lu, A Urrutia, L Chavez-Noriega, S B Ellis, E C Johnson and G Veliçelebi

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 808-816;
You have access
Mechanisms of nonlinear pharmacokinetics of mibefradil in chronically instrumented dogs.
A Skerjanec, S Tawfik and Y K Tam

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 817-825;
You have access
Ca(++)-dependence of caffeine modulation of the rate-force relation in canine cardiac Purkinje fibers.
H Satoh and M Vassalle

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 826-835;
You have access
Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
K J Schuh, S L Walsh, G E Bigelow, K L Preston and M L Stitzer

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 836-846;
You have access
Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways.
L M Renzetti, P M Paciorek, S A Tannu, N C Rinaldi, J E Tocker, M A Wasserman and P R Gater

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 847-853;
You have access
Use of chloride blockers: a novel approach for cardioprotection against ischemia-reperfusion damage.
H Tanaka, S Matsui, T Kawanishi and K Shigenobu

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 854-861;
You have access
Prejunctional alpha adrenoceptor desensitization in rat heart after chronic epinephrine treatment.
S Apparsundaram and D C Eikenburg

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 862-870;
You have access
Characterization of two cloned human CB1 cannabinoid receptor isoforms.
M Rinaldi-Carmona, B Calandra, D Shire, M Bouaboula, D Oustric, F Barth, P Casellas, P Ferrara and G Le Fur

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 871-878;
You have access
Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys.
S S Negus, N K Mello, X Lamas and J H Mendelson

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 879-890;
You have access
D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys.
N Matsuoka and T G Aigner

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 891-897;
You have access
Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl) amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models.
M Abe, R Tabata, K Saito, T Matsuda, A Baba and M Egawa

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 898-905;
You have access
Chronic in vivo and in vitro effects of amiodarone on guinea pig hearts.
E A Sosunov, E P Anyukhovsky and M R Rosen

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 906-912;
You have access
Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
A M Szczepanik, L R Brougham, J E Roehr, P G Conway, D B Ellis and C A Wilmot

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 913-920;
You have access
Ovine prolactin increases hepatic UDP-glucuronosyltransferase activity in ovariectomized rats.
M G Luquita, V A Catania, E J Sánchez-Pozzi and A D Mottino

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 921-925;
You have access
Immunomodulator OM 163-induced reversal of tumor-mediated immunosuppression and downregulation of TGF-beta 1 in vivo.
P Lagadec, S Reveneau, P Lejeune, D Pinard, T Borman, J Bauer and J F Jeannin

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 926-933;
You have access
Chloramphenicol and the inflammatory response in the rat. Upregulation of the gene for T2-kininogen in liver.
P Raymond, H Wang, C Blais, A Décarie, A Adam and R Morais

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 934-940;
You have access
A comparison of the effects of glial cell line-derived neurotrophic factor on spinal cord and cortex cerebri grafts.
K Trok, S Almström and L Olson

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 941-949;
You have access
Leukotriene B4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: regulation by lipoxin A4.
Z Feng, H P Godfrey, S Mandy, S Strudwick, K T Lin, E Heilman and P Y Wong

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 950-956;
You have access
Escherichia coli expression and substrate specificities of canine cytochrome P450 3A12 and rabbit cytochrome P450 3A6.
S L Born, D J Fraser, G R Harlow and J R Halpert

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 957-963;
You have access
Inhibition by zinc protoporphyrin-IX of vasoactive intestinal peptide-induced relaxations of guinea pig isolated trachea.
B J Undem, J L Ellis, S Meeker, A Fischer and B J Canning

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 964-970;
You have access
Pharmacokinetics and tissue disposition of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration.
R Zhang, R P Iyer, D Yu, W Tan, X Zhang, Z Lu, H Zhao and S Agrawal

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 971-979;
You have access
Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner.
M Scott and D J Carr

Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 980-988;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals